FDA Inspection 816832 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on February 1, 2013 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 1, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tallahassee, FL (United States)